Today: 9 April 2026
Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape
10 January 2026
1 min read

Credo Technology stock jumps on Needham “Top Pick” call as CEO sale filing hits tape

New York, Jan 9, 2026, 20:26 EST — Market closed

  • Shares of Credo Technology jumped roughly 6% on Friday, bouncing back after a volatile session
  • Needham reaffirmed its buy rating, maintained the $220 price target, and included the stock on its conviction list
  • A regulatory filing revealed CEO William Brennan sold shares on Jan. 7-8; investors now turn to his Jan. 14 conference appearance

Shares of Credo Technology Group Holding Ltd (CRDO) climbed 6.2% to $150.42 on Friday. Needham stuck with a buy rating, set a $220 price target, and added the AI connectivity supplier to its conviction list. The stock fluctuated between $141.34 and $157.47, valuing the company at roughly $32.5 billion. Investing.com

Money is pouring into the infrastructure supporting artificial-intelligence data centers, not just the big-name chipmakers. For smaller suppliers, one positive analyst call can spark a rapid influx of cash — and just as quickly, selling follows when the headlines shift.

Needham is banking on Credo’s Active Electrical Cable (AEC) — a copper cable with embedded electronics that connects servers to networking switches — as well as a wider move toward faster connections within AI clusters. “We encourage investors to Buy Credo on recent weakness and to focus on the signal in the current noise,” Needham analyst N. Quinn Bolton said, according to Barron’s. Barron’s

A separate filing revealed that President and CEO William Joseph Brennan offloaded 19,932 shares on Jan. 7 and 8, fetching average prices between $125.69 and $142.41 per share. The sales brought in about $2.7 million. After these transactions, Brennan still held 270,641 shares directly, plus more through a family trust. SEC

Credo has a key event coming up: it’s set to present at the 28th Annual Needham Growth Conference in New York City on Jan. 14 at 9:30 a.m. ET, according to the company’s investor website. Market watchers often see these presentations as a way for management to fine-tune demand signals ahead of earnings. Credo Technology Group

That said, the situation works both ways. Orders linked to hyperscale spending tend to be uneven, and competition is fierce in high-speed networking, where major chip and optics suppliers battle for market share. Credo’s shares, already valued on strong growth expectations, could see their multiples drop if adoption slows or customer rollouts stall.

Nasdaq projects the next earnings report to drop around March 3. Investors will probably focus on product mix and how quickly customers are deploying the offerings. Nasdaq

Next up: can Friday’s rally hold through Monday’s cash session and into the Jan. 14 conference? Investors will be watching closely for updates on AEC demand and when new product ramps might start.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away
Previous Story

BitMine (BMNR) stock slides as new CFO/COO named — and a key share vote is days away

Goldman Sachs stock edges higher before CPI and a packed week of bank earnings
Next Story

Goldman Sachs stock edges higher before CPI and a packed week of bank earnings

Go toTop